Was great, now average - Recensione dipendente - Associate Director presso MSD

4,0
24 apr 2025
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Decent pay, good team, nice offices

Svantaggi

As key drug Keytruda approaches end of patent, company is in flux. Cost cutting and pressure increase.

Esplora altre recensioni su MSD

5,0
2 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Work culture Fantastic colleagues Sense of purpose

Svantaggi

Location: Not in west coast

5,0
20 mag 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Strong processes and focus on excellence

Svantaggi

Large company is slower to pivot, makes innovation more difficult

Vedi recensioni per: Utile|Valutazione|Data|Tutto